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Zinc intake, status and indices of cognitive function in adults
and children:Q1 a systematic review and meta-analysis
M Warthon-Medina1, VH Moran2, A-L Stammers1, S Dillon1, P Qualter3, M Nissensohn4, L Serra-Majem5 and NM Lowe1
In developing countries, deﬁciencies of micronutrients are thought to have a major impact on child development; however,
a consensus on the speciﬁc relationship between dietary zinc intake and cognitive function remains elusive. The aim of this
systematic review was to examine the relationship between zinc intake, status and indices of cognitive function in children and
adults. A systematic literature search was conducted using EMBASE, MEDLINE and Cochrane Library databases from inception to
March 2014. Included studies were those that supplied zinc as supplements or measured dietary zinc intake. A meta-analysis of the
extracted data was performed where sufﬁcient data were available. Of all of the potentially relevant papers, 18 studies met the
inclusion criteria, 12 of which were randomised controlled trials (RCTs; 11 in children and 1 in adults) and 6 were observational
studies (2 in children and 4 in adults). Nine of the 18 studies reported a positive association between zinc intake or status with one
or more measure of cognitive function. Meta-analysis of data from the adult’s studies was not possible because of limited number
of studies. A meta-analysis of data from the six RCTs conducted in children revealed that there was no signiﬁcant overall effect of
zinc intake on any indices of cognitive function: intelligence, standard mean difference of o0.001 (95% conﬁdence interval
(CI) –0.12, 0.13) P= 0.95; executive function, standard mean difference of 0.08 (95% CI, –0.06, 022) P= 0.26; and motor skills standard
mean difference of 0.11 (95% CI –0.17, 0.39) P= 0.43. Heterogeneity in the study designs was a major limitation, hence only a small
number (n= 6) of studies could be included in the meta-analyses. Meta-analysis failed to show a signiﬁcant effect of zinc
supplementation on cognitive functioning in children though, taken as a whole, there were some small indicators of improvement
on aspects of executive function and motor development following supplementation but high-quality RCTs are necessary to
investigate this further.
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INTRODUCTION
Brain growth and development are critically dependent on several
micronutrients.1–3 Zinc is a key modulator of intracellular and
intercellular neuronal signalling4 that is found in high levels in the
brain particularly the hippocampus, considered as the area
involved in learning and memory,5–7 and in the amygdala,
striatum and neocortex.7–9 Zinc is essential for the activity of a
large number of metalloenzymes, cellular functions including RNA
and DNA synthesis,10 cellular growth, differentiation and metabo-
lism. During early development, cellular activity may be particu-
larly sensitive to zinc deﬁciency, which has been shown to
compromise cognitive development.11,12 Experimental studies in
animals have shown that, during the early stages of brain
development, deﬁciency of zinc caused brain defects,13 reducing
the cerebellum size14 and altering zinc homeostasis,15 whereas
zinc deﬁciency during the latter stages of brain development
impaired function.16 Zinc-deﬁcient rats experienced diminished
learning and some working memory deﬁcit17–20 and pups whose
dams have suffered prenatal zinc deﬁciency tend to be more
aggressive than pups whose dams suffered prenatal
undernutrition.21 Evidence in humans, however, is less clear and
the exact role of zinc on brain function and cognitive develop-
ment remain poorly understood.11,22–25
It has been estimated that 20% of the world population are zinc
deﬁcient26 and countries with a prevalence of poor dietary zinc
intake of 425% are considered at high risk of zinc deﬁciency.27
Zinc deﬁciency occurs in individuals and populations whose diets
are low in sources of readily bioavailable zinc (such as red meat
and seafood) and high in unreﬁned cereals (rich in phytate and
dietary ﬁbre).28–30 These dietary patterns are characteristics that
are common in many developing countries where zinc deﬁciency
has a major impact on child development.12,31,32 The precise role
of zinc in cognitive function is still unclear, however, zinc is
present in relatively high concentrations in the hippocampal and
neocortical regions of the brain. Much of the evidence for the role
of zinc in the function of the central nervous system has come
from animal studies, which have shown that zinc deﬁciency results
in reduced activity, poor memory and attention,33 also in offspring
rats, zinc deﬁciency during the last trimester of pregnancy and
during lactation impaired spatial learning and memory and had a
negative effect on motor activity.18 Although studies in humans,
the observational studies have suggested a relationship between
zinc deﬁciency and poor cognition, but the evidence from
randomised controlled trials (RCTs) during infancy, pregnancy
and lactation has shown little effect.34 The essential role of zinc in
the central nervous systems is marked during brain growth,
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particularly between 24 and 40 weeks after conception,3 which is
the period where the brain goes through extraordinary structural
changes, and it is during this critical time that the brain is most
sensitive of zinc deﬁciency and its deﬁciency will affect the
involvement of zinc in various enzymes and neurochemical
processes such as synaptic transmission and the release of
neurotransmitters.35
The speciﬁc question we sought to address in this systematic
review was 'what is the evidence for an association between zinc
intake, through diet or supplement, zinc status (plasma zinc
concentration), and indices of cognitive function in adults and
children?'. A narrative review is presented in this article, along with
a meta-analysis of the data was undertaken where studies were
sufﬁciently homogenous in terms of their design and the
outcomes measured. This review was part of a wider systematic
review process to identify studies assessing the relationships
between zinc intake, status and various health outcomes in health
populations within the EURRECA (European Micronutrient Recom-
mendations Aligned) framework.36
MATERIALS AND METHODS
Search strategy
The databases Ovid MEDLINE, Ovid Embase and the Cochrane
Library were used to search for relevant papers from inception,
initially to February 2010, and then updated to March 2014. Both
indexing and text terms were used and languages included were
restricted to those spoken in the EURRECA network (English,
Dutch, French, German, Hungarian, Italian, Norwegian, Polish,
Spanish, Greek or Serbian).
The search and paper selection procedures were conducted
according to EURRECA protocols.37,38 The full Ovid MEDLINE
search strategy can be found in Table 1. Reference lists of
retrieved articles and published literature reviews were also
checked for relevant studies. Authors were contacted to request
missing data or clarify methods or results, some replied to our
request and data values were used in the analysis, if no reply from
the author, the study was excluded or additional conversion of
data was performed, for example, transforming interquartile
ranges (IQRs) to s.d. The search process is illustrated in Figure 1.
It should be noted that these search strategies were part of the
wider zinc systematic review that investigated a range of intake–
status–health relationships, which refers to the study of the
relationship between zinc intake and status, zinc intake and
health, and zinc status and health outcomes that were considered
within EURRECA.39 The search was therefore intentionally broad in
order to capture a range of health outcomes, which is the reason
for the high number of identiﬁed studies and the relatively low
proportion of relevant cognitive studies. The updated search
followed the same search strategy. Details of the search, selection,
data extraction and statistical methods developed and used by
the EURRECA consortium can be access at www.eurreca.org.
Inclusion/exclusion criteria. The titles and abstracts were
screened and sorted on the basis of predeﬁned inclusion criteria:
relevant to the research question, human study, zinc intake–
Table 1. Search strategy: EMBASE, MEDLINE March 2014
Search
no
Search term Results Search
type
1 randomized controlled trial.pt 366 322 Advanced
2 controlled clinical trial.pt 87 769 Advanced
3 randomized.ab 656 647 Advanced
4 placebo.ab 343 941 Advanced
5 clinical trials as topic.sh 168 553 Advanced
6 randomly.ab 457 059 Advanced
7 trial.ab 677 661 Advanced
8 randomised.ab 131 650 Advanced
9 6 or 3 or 7 or 2 or 8 or 1 or 4 or 5 1 903 586 Advanced
10 (animals not (human and animals)).sh 5 241 748 Advanced
11 9 not 10 1 777 274 Advanced
12 (cohort* or ''case control*'' or cross-sectional* or ''cross sectional'' or case-control* or prospective or ''systematic*
review*'').mp
2 423 333 Advanced
13 exp meta-analysis/ or exp multicenter study/ or follow-up studies/ or prospective studies/ or intervention
studies/ or epidemiologic studies/ or case-control studies/ or exp cohort studies/ or longitudinal studies/ or
cross-sectional studies/
3 389 546 Advanced
14 13 or 12 4 207 248 Advanced
15 14 not 10 4 131 683 Advanced
16 11 or 15 5 304 597 Advanced
17 ((zinc or zn or ''zinc sulphate'' or ''zinc gluconate'' or ''zinc acetate'' or methionine or ''zinc isotope*'') adj3 (intake* or
diet* or supplement* or deplet* or status or serum or plasma or leukocyte or concentration* or expos* or fortif* or
urine or hair)).ti,ab.
45 693 Advanced
18 Nutritional Support/ or Dietary Supplements/ or nutritional requirements/ 140158 Advanced
19 exp Nutritional Status/ or exp Deﬁciency Diseases/ or supplementation/ or diet supplementation/ or dietary intake/
or exp diet restriction/ or exp mineral intake/ or Diet/ or Food, Fortiﬁed/ or nutrition assessment/ or Nutritive Value/
or Breast feeding/ or exp infant food/ or bottle feeding/ or infant formula/
786125 Advanced
20 (intake* or diet* or supplement* or deplet* or status or serum or plasma or leukocyte or concentration* or expos* or
fortif* or urine or hair).ti,ab.
8 833 552 Advanced
21 18 or 19 or 20 9 146 891 Advanced
22 zinc/ 132 400 Advanced
23 22 and 21 72 546 Advanced
24 23 or 17 88 668 Advanced
25 16 and 24 9230 Advanced
26 limit 25 to humans 7899 Advanced
27 limit 26 to yr= ”2013 -Current” 672 Advanced
Embase 1974 to 2014 week 09, Ovid MEDLINE(R) 1946 to February 2014 week 04.
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plasma/serum zinc status–cognition relationship, reviews, RCTs,
cohort studies, cohort nested case–control studies and cross-
sectional studies. Included studies were those conducted in
apparently healthy human populations that supplied zinc
supplementation either as zinc gluconate, zinc sulphate, zinc
acetate, zinc picolinate or zinc oxide or measured dietary
zinc intake with either a validated food frequency questionnaire,
a dietary history method, a 24-h recall method for at least 3 days
or a food record/diary for at least 3 days (observational studies),
which are established best practise methods.36,40 For studies to
be included in this review, both zinc intake/status measurement
had to occur either in adults or children. Thus, intervention and
observational studies reporting zinc intake/status and cognitive
domains in adults and children were included. Studies were
excluded if they were non-RCT, a group RCT (community trial),
case–control studies, or uncontrolled trials (an intervention
without a control group) or were commentaries, reviews or
duplicate publications from the same study. Of all studies
included in the strategic review, only those RCTs in children
reporting sufﬁcient data on zinc intake/status and cognitive
domains were included in the subsequent meta-analysis.
This review focused on studies conducted in children (aged 1 to
o18 years), and adults (≥ 18 years). Studies relating to infants
(aged 0–12 months) were excluded from this review because the
systematic review and meta-analyses in infants were conducted
by the research team at ULPGC and reported elsewhere.41
Data extraction
For each of the studies, data were extracted independently by two
reviewers and input into a standardised database. Extracted data
included population characteristics, dose of zinc in intervention
studies, duration of the study, dietary intake of zinc, mean
concentration of zinc in plasma or serum for observational studies
and measures of cognitive function. Unit conversions to μmol/l
were performed for the observational studies, which reported μg/
dl for serum/plasma zinc concentrations. Variances that were
provided as IQRs were converted to s.d., using the following
formula: s.d. = IQR/1.35 where IQR = 75th percentile–25th percen-
tile. The characteristics of these studies are presented in Tables 2a
and 2b. A database of the references found in the systematic
search can be found on the EURRECA website.42
Assessment of risk of bias in included studies
The criteria for assessing risk of bias of the included RCTs were
adapted from the Cochrane Handbook for Systematic Reviews.43
Records excluded (n=1640)
Reasons include: no measure of cognitive function, focus
on topics not included in this review (e.g. toxicology,
mood or depression, mental health, attention deficit
hyperactivity disorder). Not conducted in selected age
groups, no plasma/serum zinc or zinc intake data reported.
(Included N° of studies identified for cognitive outcome
and excluded n=18, reasons: reviews, meta-analyses,
rating scores, multiple micronutrients).
Duplicate studies removed (n=4125)
Titles and abstracts identified from electronic
search (n= 9753) and reviews (n=7)
Intake-Status-Health relationship
Abstracts screened
(n=5635)
Records excluded (n= 3447)
Reasons include:  no zinc intake-status-
health associations reported, not eligible
study design, not eligible zinc
biomarker, not eligible health outcome.
Publications reporting zinc and indices of cognitive function that
meet the EURRECA inclusion criteria (n=18)
Randomised Controlled Trials
Children (n= 11)
Adult (n=1)
Observational studies
Children (n= 2)
Pregnant women (n= 1)
Adult (n=3)
Full text articles assessed for eligibility
(n= 2188)
(Included N°of studies from updated search to
March 2014 (n=13)
Intake-status-health Infant studies (n= 356)
Included in the meta-
analysis from Children
group (n= 6)
Intake-status studies (n= 174)
Figure 1. Study selection process for the systematic review.
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Studies were not included or excluded on the basis of their quality
assessment. Rather the assessment of study quality provides a
context for interpreting the reported effect sizes. The criteria for the
RCTs and observational studies are presented in Tables 4a and 4b,
respectively. Based on these indicators, two reviewers decided on
the overall risk of bias. Disagreements were resolved by discussion.
Meta-analysis
Meta-analysis of data extracted from six RCTs conducted in
children was undertaken using Review Manager (v5.2)Q4 . RCT studies
that were included for meta-analysis were those which measured
one of the following cognitive domains: intelligence, executive
function and motor development. These outcomes are described
in Table 3 with corresponding studies, the test used and the
function assessed. All data input for meta-analysis were cross-
checked (NML and VHM). All RCTs were grouped per population.
Of the RCTs in children, those that measured the same cognitive
outcome were subgrouped, and those which provided sufﬁcient
outcome data (mean and s.d.) were included in the meta-analysis.
Owing to the different scales used by the cognitive tests, the
standardised mean difference was used in the random effects meta-
analysis. For the quantiﬁcation of heterogeneity between studies the
(I)2 value was used.44 Studies were also sorted by effect size, deﬁned
as the measurement of the magnitude of the phenomenon.45 The
limited data available from observational studies meant that it was
not possible to combine these studies in a meta-analysis.
RESULTS
Selection of articles
A diagram illustrating results of the systematic search and
selection process is presented in Figure 1. A total of 5635 articles
Table 3. Categorisation of cognitive function tests
Aspects of cognitive
function
Cognitive test Speciﬁc functions assessed by test Study
reference
Motor skills CPAS-R Assesses cognitive abilities, interests and dispositions by questionnaires 62,63
Gross motor scale Development of gross motor function 65
McCarthy scales of children’s
abilities
Measures mental and motor abilities 67
MABC, ﬁnger tapping Assessment of motor coordination, motor speed and dexterity 57,60
Grooved pegboard,
dominant, non-dominant
hands
Manipulative dexterity 65
Concept formation Draw a person 61
Trails, part B, Visuomotor tracking and attention 52
Executive function:
memory
CANTAB: PRM Visual memory 56,62
Spatial span, SWM, DS Working memory 56,59
Visual and auditory sequential
memory
Visual or auditory memory span 65
Short-term memory Storage of information for a limited period 50
Visual memory 51
Buschke recall Short and long-term storage, retention of the total recall 52
Heaton recall Memory for geometric forms 52
Blessed items, Concentration and memory 52
Category ﬂuency The subject names as many animals as possible in 1min 52
Stroop test Inhibitory control 57,60
Animal ﬂuency test measure of executive function 54
The IU story recall test Memory 54
Attention SRT, RRT, reaction time, MTS Measures attention, cognitive speed for reaction tasks 51,56
Attention span scores Length of time to concentrate 64
MMSE Screen dementia, measures orientation, registration, attention, calculation,
memory, language skill
52,53
Global cognitive function CSID, CERAD word list recall. CSID, screening tool for dementia 54
PMSQ Cognitive capacity 53
Language Bear story, number concepts,
CERAD
Language and narrative development 61
The IU token test Measure of language comprehension and working memory 54
Intelligence Verbal, non-verbal ability,
general conceptual ability IQ
Differential ability scales, IQ is the ratio of tested mental age to
chronological age and is expressed as a quotient multiplied by 100
65
Binet–Kamath scale Determine the level of intellectual and cognitive functioning 50
UNIT The UNIT provides a comprehensive assessment of non-verbal intelligence 57
WISC-III Measures intellectual functioning 58
RAVEN CPM Test of non-verbal intelligence 51,58,59,67
WPPSI Assess cognitive and intellectual abilities 61
DTLA Measures general and speciﬁc mental abilities 66
Abbreviations: CANTAB, Cambridge automated neuropsychological test battery; CERAD, consortium to establish a registry for Alzheimer’s disease; word list
learning test; the CERAD word list recall test; CPAS, cognitive psychometric assessment; CPAS-R, cognition-psychomotor assessment system-revised; CSID,
community screening instrument for dementia; DTLA, Detroit tests of learning aptitude; DS, digit span; IU, the Indiana University; the IU story recall, the IU
token test; IQ, intelligent quotient; MABC, movement assessment battery for children; MMSE, mini-mental state examination; MTS, matching to sample visual
search; PMSQ, Pfeiffer’s mental status questionnaire; PRM, pattern recognition memory; RAVEN CPM/RCPM, Raven’s coloured progressive matrices test; RPM,
Raven’s progressive matrices; RRT, recognition reaction time; SRT, simple reaction time; SWM, spatial working memory; UNIT, universal non-verbal intelligence
test; WISC-III, Wechsler intelligence scale for children-third edition; WPPSI, Wechsler preschool and primary scale of intelligence.
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were identiﬁed as potentially relevant for inclusion in the wider
search on zinc intake, status and health outcomes in all
populations. Of these, 3447 were excluded based upon screening
abstracts. Two independent reviewers screened 10% of the
abstracts in duplicate and any discrepancies were discussed
before screening the remaining references. A further update to
the search in March 2014 found 13 further relevant articles. The
full texts of the remaining 2188 manuscripts were assessed to
determine inclusion and exclusion by two independent reviewers
and disagreements rectiﬁed through discussion. A total of 1640
studies were excluded because they did not meet the inclusion
criteria. In all, 174 studies relating to zinc intake–status
Figure 2. Forest plots of RCTs of intelligence, executive function and motor outcome in children. (a) The effect of zinc supplementation on
intelligence in children. (b) The effect of zinc supplementation on executive function in children. (c) The effect of zinc supplementation on
motor outcome in children.
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relationships have been reported elsewhere,46–48 and 356 infants
studies were also passed to another team within the EURRECA
network for a separate review.49 The ﬁnal selection included 12
RCTs (11 in children) and 6 observational studies, all of which were
published between 1985 and 2009.
Reasons for exclusion
A total of 3447 abstracts were excluded, for the following reasons:
no zinc data, no baseline data, no measurement of the relation-
ship of zinc intake/status with cognition, ineligible study design,
ineligible dietary zinc measurement (that is, neither validated food
frequency questionnaire, dietary history method nor a 24-h recall
for at least 3 days), or ineligible biomarker of zinc (that is, neither
plasma/serum, urine nor hair zinc concentrations). For the purpose
of this review, studies with infant were not included (n= 356) as
this has been reported elsewhere.41 A further 1814 studies were
excluded because they did not assess cognitive function out-
comes or they provided insufﬁcient data to be considered for a
comparative analysis, were not conducted on healthy participants,
provided zinc as a multi-micronutrient supplement or were
published in a language outside the scope of this study.
Studies included. A total of 18 studies that reported zinc intake or
plasma/serum zinc and its association with cognitive function met
the inclusion criteria. Twelve were RCTs and six were observational
studies. A summary of the key characteristics of these studies are
given in Tables 2a and 2b. Studies were conducted in Europe
(n= 3), North America (n= 3), Asia (n= 8), Africa (n = 2), Central
America (n= 1) and South America (n= 1) and age of participants
ranged from 23 to 94 years for adults (including pregnant
women), and 3–16 years for children. In the majority of studies
included in this article, children were under 10 years old; only two
studies included older children.50,51
Adults and pregnant women. A small number of studies included
in this review (5 of 18) addressed the relationship between zinc
intake and/or status on cognitive function in adults, four of which
were observational cross-sectional studies52–55 and one was an
RCT.56 The search identiﬁed only one observational study
conducted in pregnant women.55 Meta-analyses of adults or
pregnant women could not be performed because of the
variability in the presentation of the data and the lack of
comparable studies.
Children. Eleven RCTs51,57–66 and two observational studies50,67
were conducted with children. In ﬁve studies, supplements were
given before cognitive testing; either prenatally to pregnant
women between 10 and 19 weeks of gestation with children
assessed for cognitive skills at age 4–9 years60,61,65 or postnatal
supplementation for up to 2 years (4–35 months old), with
cognitive skills assessed in a follow-up at age 7- to 9-year old57 or
mean age of 9.3-year old.58 For these studies, supplements were
given in the form of a caplet,60 tablet57,61,65 or in a form of syrup.58
The remaining six RCT studies assessed cognitive function
immediately after supplementation51,59,62–64,66 in children aged
on average 81.5 months66 and 7.6-year old59 and age ranging
from 5- to 7-year old,64 6- to 9-year old62,63 and 10- to 16-year
old.51 Participants were given zinc supplements, either in the form
of a zinc sulphate solution64 as a tablet51,62,63,66 or as a meat
supplement.59 The two observational studies compared plasma
zinc concentrations with cognitive function in children aged 3- to
5-year67 and 6- to 11-year old.50
Indices of cognitive function. The indices of cognitive develop-
ment and function used in the studies included in this review are
summarised in Table 3. They included measures of motor skills,
executive function (memory, attention, language and global
cognitive function) and intelligence. Of the 18 studies described
in Tables 2a and 2b, nine reported a positive association between
zinc intake or status with one or more measure of cognitive
function.50,51,53,55,56,59,62,63,67 Negative associations or no
signiﬁcant effect were reported for the remaining nine
studies.52,54,57,58,60,61,64–66
Meta-analysis of data from studies with children
A random effects model was used to investigate the impact of zinc
intake on indices of cognitive function including intelligence (six
data sets from ﬁve publications),57,58,61,65,66 executive function (six
Figure 2. Continued.
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data sets from four publications)57,61,64,65 and motor development
(four data sets from three publications).57,61,65
The analysis yielded a pooled standard mean difference for the
impact of zinc supplementation on intelligence of o0.001 (95%
conﬁdence interval (CI) −0.12, 0.13) P= 0.95; executive function,
0.08 (95% CI, − 0.06, 022) P= 0.26 and motor skills, 0.11 (95% CI
− 0.17, 0.39) P= 0.43. These results revealed no signiﬁcant overall
effect of zinc supplementation on these cognitive function
domains (Figures 2a–c, respectively). Stratifying the data by
subgroups based on whether the child was given the supple-
ments or given prenatally to the mother, revealed that maternal
supplementation during pregnancy did not have a signiﬁcant
impact on these cognitive domains in children assessed during
childhood. For trials in which the supplements were given directly
to the child, there was a signiﬁcant effect of supplementation on
executive function (mean difference = 0.21, 95% CI 0.06, 0.36,
P= 0.006) and motor skills (mean difference = 0.34, 95% CI 0.19,
0.50, Po0.0001; Figures 2b and c). However, this must be
interpreted with caution because of the limited number of data
sets contributing to these analyses, two of which come from the
same study.57
Risk of bias
The risk of bias for each study identiﬁed was assessed. Twelve
RCTs studies were assessed and a high risk of bias was found for
most of the studies, except for three,57,58,60 which had moderate-
to-low risk of bias (Table 4a). Six observational studies were
assessed, and a moderate risk of bias was found for most of the
studies, except for two,50,67 which had high risk of bias and one,55
which had low risk of bias (Table 4b). The sources of bias included
inadequate information about sources of funding, unclear
adequacy of sequence generation (randomisation procedure)
and inadequate blinding.
DISCUSSION
The purpose of this review was to present the evidence for the
relationship between zinc intake and/or zinc status (plasma/serum
zinc concentration), and indices of cognitive function in adults
(⩾18 years) and children (aged 1 to o18 years). This review differs
from other reviews in that it includes both intervention and
observational studies that investigated the association between
zinc intake, through diet or supplement, zinc status (plasma/serum
zinc concentration), and indices of cognitive function in adults and
children and a short meta-analyses of studies in the child group.
Narrative overview
Adult and pregnant women. Of the ﬁve studies identiﬁed,52–56
three suggested a positive association between zinc intake and
measures of cognitive function.53,55,56 Ortega et al.53 indicated a
small but signiﬁcant correlation (r= 0.135, Po0.05), between
increased zinc intake and mini-mental state examination test.
Stoecker et al.55 reported a positive correlation between plasma
zinc concentration and Raven’s coloured progressive matrices test
scores, a test of non-verbal intelligence, in women in their third
trimester of pregnancy (r= 0.27, Po0.008). Results revealed a
weak, positive association between the test score and plasma zinc
concentration. The study by Maylor et al.56 indicated both a
positive signiﬁcant effect of zinc supplementation on memory
(P= 0.030) and a negative signiﬁcant effect on indices of attention
(matching to sample visual search; P=− 0.015). Two studies
examined the association between plasma zinc concentration
and cognitive score.52,54 One of these revealed that lower plasma
zinc was signiﬁcantly correlated with poor cognitive performance
in women (P= 0.008) but not in men,52 whereas the other study54
failed to ﬁnd any association in men or women.
Children—executive function. The studies included in this review
reported contrasting outcomes of the relationship between zinc
intake/status on indices of executive function, including attention,
inhibitory control, memory and language. Gibson et al.64 reported
that zinc supplementation had no signiﬁcant effect on attention
span in boys aged 5− 7 years, which was consistent to the
ﬁndings reported by Tamura et al.65 in a group of girls and boys of
a similar age. In contrast, a positive association was reported
between zinc intake and the digit span scores test, which
measures verbal working memory ability, in children59 and
adolescent girls.51 In the studies where the supplements were
given prenatally, no effect was reported on working memory or
inhibitory control57,60 or language development.61
Children—intelligence. Intelligence was measured using a variety
of tests detailed in Table 3. Cavan et al.66 reported that zinc
supplementation in children had no signiﬁcant effect on the total
cognitive score of the Detroit tests of learning aptitude, which
tests general mental abilities,68 although children did responded
to zinc supplementation with signiﬁcant changes in cognitive
scores.66 This concurs with the results of the study by Gewa et al.59
conducted in children in Kenya in which children’s diets were
supplemented with meat in order to increase their overall zinc
intake. After 2 years, there were no signiﬁcant differences in Raven
test scores between the children consuming additional meat,
compared with those consuming the control diets. Furthermore,
prenatal zinc supplementation did not have a signiﬁcant effect on
Table 4a. Assessment of risk of bias of included randomised controlled trials reporting zinc intake and serum/plasma zinc in children and adults
(adapted from the Cochrane handbook)
Study Adequate
sequence
generation
Allocation
concealment
adequate
Adequate
blinding
Dropouts adequate
and outcome data
complete
Funding
adequate
Lack of other
potential threats
to validity
Overall
risk
of bias
Maylor et al.56 Unclear Unclear Yes Yes Yes Unclear High
Tamura et al.65 Yes Unclear Yes Unclear Yes Unclear High
Penland et al.62 Unclear Unclear Yes Unclear Yes Unclear High
Tupe and Chiplonkar51 Unclear Unclear Yes Unclear Yes Unclear High
Murray-Kolb et al.57 Unclear Yes Yes Yes Yes Yes Moderate
Pongcharoen et al.58 Yes Yes Yes Yes Yes Yes Low
Gewa et al.59 Unclear Unclear No Yes Yes Unclear High
Christian et al.60 Unclear Yes Yes Yes Yes Yes Moderate
Caulﬁeld et al.61 Yes Yes Yes Yes No Yes High
Sandstead et al.63 Unclear Unclear Yes Unclear Yes No High
Gibson et al.64 Unclear Yes Yes Yes No Yes High
Cavan et al.66 Unclear Unclear Yes Unclear Yes No High
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any indices of intelligence measured in children aged 4–9
years.60,61,65
A follow-up study in which zinc supplements were given to
children from 12 to 35 months, indicated that there were
signiﬁcant improvements in intellectual function scores in the
zinc supplemented group compared with the placebo control
group when children were followed up at 7–9 years of age.
However, when adjustments were made for co-variants, the
difference was not signiﬁcant.57 A study of similar design also
reported no long-term effects of zinc supplementation given from
4 to 6 months, on indices of intelligence at age 9.3 s.d. (0.3)
years.58
Children—motor skills. Penland et al.62 undertook a study in
Chinese children of the impact of 10 weeks supplementation with
zinc alone or zinc plus miconutrients or micronutrients alone, on
indices of motor function. The test used was the cognition-
psychomotor assessment-revised (CPAS-R) battery, which revealed
that zinc, and zinc with micronutrients, signiﬁcantly improved
performance in all subtests of the CPAS-R battery. In addition,
Sandstead et al.63 showed that zinc plus micronutrients signiﬁ-
cantly improved neuropsychologic performance including the
tasks of tapping, circular tracking (motor) and oddity (concept
formation) compared with micronutrients or zinc alone. Hubbs-
Tait et al.67 reported a negative association between plasma zinc
concentration and motor scores from the motor subset within the
McCarthy scales of children’s ability test. Prenatal zinc supple-
mentation did not have a signiﬁcant effect on motor score in a
follow-up study of children aged 5.3 (s.d. 0.3) year.65
Meta-analysis. One of the challenges researchers encounter
when comparing studies in this ﬁeld is the broad variety of study
designs and outcome measures used. For the meta-analysis part
of this review, only RCTs conducted in children were included,
with outcome measures clustered into three main cognitive
domains: intelligence, executive function and motor outcome.
Reasons for excluding studies from meta-analyses included: only
percentage change in measurements reported,51 lack of control
group,62,63 test scores reported as differences rather than the
mean and s.d. data for both intervention and placebo group to
enable analytical comparison.59
Results from the meta-analyses of the impact of zinc
supplementation on cognitive domains in children indicated that
supplements given prenatally did not have a long-term impact on
offspring during childhood but supplements given directly to
children may have a positive impact on executive function and
motor skills. Despite the small number of studies that were eligible
for the meta-analysis, it could be argued that the usefulness of this
meta-analysis lies in the analyses per cognitive domain and in the
categorisation of prenatal supplementation and supplements
given to children that add an insight into the effect of zinc
supplementation in both situations. Irrespective of the instrument
used (UNIT, WISC), it was considered a logical process to combine
studies that measured intelligence and similarly this was done for
executive function and motor outcome. Well-designed RCT
studies,69 which follow standardised measurement techniques to
facilitate direct comparison of outcome data with other studies,
are required to measure zinc intake and/or status and cognitive
function relationships
Comparisons with ﬁndings from other studies
The narrative review in this article highlights the limited number
of studies looking at the association between zinc intake/status
and cognitive function, particularly in the adult and children
populations. The main ﬁndings of this review are the evaluation of
the range of cognitive aspects that were assessed in the included
studies in the narrative review (memory, attention, cognitive
score, performance, motor skills, intelligence, language and
inhibitory response) and its association with zinc intake and/or
plasma zinc status, where 9 studies out of 18 reported a positive
association. In addition, evidence from the six RCTs conducted in
children that examined the effect of zinc supplementation either
pre or post-nataly, revealed that the overall pooled standard mean
difference of the impact of zinc supplementation on intelligence,
executive function and motor outcome was not signiﬁcant. The
strength of this systematic review is in the unique methodology of
the deﬁned criteria of identifying zinc intake, biomarker of zinc
status and the health outcome cognitive function identiﬁed,
following a thorough systematic review process following EUR-
RECA best practises and guidelines.
Recent reviews of children and zinc supplementation for mental
and motor development have found no convincing evidence that
zinc supplementation has a beneﬁcial effect on motor or mental
development. A recent Cochrane review70 used a different meta-
analytical approach to the one used in the present review,
including both infants and children together, and reported no
effect of zinc on intelligence, executive function or motor
development in children from birth up to 5 years of age. This
review, however, focussed on neonates, infants and toddlers up to
5 years of age, rather than older children.70 Similarly, Brown et al.71
conducted a review on zinc supplementation of children up to
30 months of age and reported no signiﬁcant overall impact on
mental and motor development.
Other reviews have examined the effect of multi-micronutrient
supplementation on cognition rather than zinc alone.72,73 Best
et al.72 concluded that four of six included studies reported a
signiﬁcant (Po0.05) beneﬁcial effect of multi-micronutrient food
fortiﬁcation on memory and Eilander et al.73 reported a signiﬁcant
overall effect of micronutrient supplementation on academic
performance (P= 0.044), but not for crystallised intelligence (the
acquiring of knowledge and learning that considers short-term
memory, visual perception, retrieval ability, cognitive processing
speed and sustained attention).73 A recent review by Nyaradi
et al.74 examined the role of nutrition on children’s neurocognitive
development from pregnancy through childhood and reported
that evidence from observational studies suggests that multiple
micronutrients may have an important role in children’s cognitive
Table 4b. Assessment of risk of bias of included observational studies reporting zinc intake and serum/plasma zinc in children and adults (adapted
from the Cochrane handbook)
Study List confounders
in review list
Study dealt with
confounding factors
adequately
Assessment of exposure
(zinc intake or status)
adequate
Information on
funder adequate
Lack of other potential
threats to validity
Overall
risk of
bias
Ortega et al.53 Yes Yes Yes No Unclear Moderate
Gao et al.54 Yes Unclear Yes Yes Yes Moderate
Lam et al.52 Yes Yes Yes Yes Yes Moderate
Stoecker et al.55 Yes Unclear Yes Yes Yes Low
Hubbs-Tait et al.67 Unclear No Yes Yes Yes High
Umamaheswari et al.50 Unclear Unclear Yes Yes Yes High
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development, with the results of intervention trials using single
micronutrients remaining inconclusive. It is difﬁcult to determine a
speciﬁc effect of zinc intake or status on indices of cognition,
partly because of the methodological challenges of assessing
long-term cognition effects, but also because the identiﬁcation of
'at risk populations' (identiﬁed vulnerable population exposed to
zinc deﬁciency) seems to be a key factor in disentangling the
impact of supplementation on cognitive outcomes.75
The major limitation in the interpretation of the meta-analysis is
the paucity of data that could be included because of the
difference of the study design and the type of cognitive test
administered per cognitive domain. In addition, many of the
studies included in our meta-analysis were assessed as having
moderate-to-high risk of bias, which may have impacted on the
reported pooled effect sizes. Limits on the number of studies
eligible for meta-analysis, however, meant that we were unable to
restrict meta-analyses to studies at low (or lower) risk of bias, or to
stratify studies according to risk of bias. Furthermore, a reliable
and speciﬁc biomarker of zinc status has not yet been identiﬁed.76
However, our previously published systematic review of biomar-
kers of zinc status have conﬁrmed that, in healthy individuals,
plasma zinc concentration does respond to changes in dietary
intake.77 All the studies included in this review were conducted in
healthy individuals, therefore we are conﬁdent that plasma zinc
concentration (although not perfect) is a reasonable biomarker for
zinc status, and is widely used as such in the studies reported in
this review despite poor sensitivity and speciﬁcity.78,79
CONCLUSIONS
Although some studies report a positive effect of zinc intake/
status on cognitive function,50,51,53,55,56,59,62,63,67 others reported
mixed results.52,54,57,58,60,61,64–66 Therefore, to date, the evidence
regarding the effect of zinc intake or status on cognitive function
is lacking and inconsistent. Therefore, although the meta-analysis
of a subset of the studies conducted in children showed no
signiﬁcant overall effect of zinc supplementation on any of the
identiﬁed cognitive domains, a positive effect of zinc supplemen-
tation on cognitive function cannot be ruled out. However, there
remains a paucity of well-designed carefully controlled long-term
trials investigating the relationship between zinc intake, status and
cognitive function in humans. Studies should be reported in a
consistent and standardised manner or in comparable units of
measurement to facilitate future comparisons and more readily
contribute to the body of scientiﬁc evidence.
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